开发一种基于纳米粒子的肌向药物输送系统,以药理学上调节肌愈合
Emmanuela Adjei-Sowah1,2, Indika Chandrasiri1,2, Baixue Xiao1,2
1Department of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.
Science advances
|June 19, 2024
概括
研究人员开发了一种向的纳米粒子药物递送系统,以改善肌愈合. 这种新的方法提高了对受伤肌的治疗效果,促进了受伤后更好的功能和机械恢复.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 肌肉骨研究 研究
背景情况:
- 肌受伤往往导致纤维化,损害愈合,导致功能不良的结果.
- 目前用于肌愈合的药理疗法受伤部位药物输送不良限制.
- 迫切需要有效的疗法来增强肌的修复和减少纤维化.
研究的目的:
- 开发一个有针对性的药物输送系统,以加强对愈合肌的治疗输送.
- 研究一种基于纳米粒子的系统的潜力,该系统与TRAP结合 (TBP) 功能化,用于肌修复.
- 评估通过TBP功能化纳米颗粒传递的尼古拉胺在改善肌愈合方面的疗效.
主要方法:
- 利用空间转录组学数据来识别在愈合肌中的耐酸酸酶 (TRAP) 表达.
- 开发了TRAP结合 (TBP) 功能化纳米颗粒 (NP) 作为药物递送系统 (DDS).
- 通过免费药物和TBP-NP配方 (TBP-NPNEN) 系统使用S100a4抑制剂尼古拉胺 (NEN).
主要成果:
- 在愈合的肌中确认了TRAP活动,验证了DDS的目标.
- 系统输送的自由尼克洛萨米德并没有显著改善肌愈合.
- TBP-NPNEN治疗显著提高了愈合肌的功能和机械恢复.
结论:
- 针对TRAP的纳米颗粒药物输送系统显示了增强肌愈合的巨大潜力.
- TBP-NP DDS有效地将尼克洛萨米德输送到愈合肌,改善治疗结果.
- 这种有针对性的药物输送方法提供了一个有希望的策略,以克服系统性药物输送用于肌修复的局限性.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...


